SCNN1B FUNCTIONS AS A TUMOR SUPPRESSOR IN COLORECTAL CANCER BY INHIBITING RAS-RAF-MEK-ERK PATHWAY

被引：0
|
作者：
Yun, Qian [1 ]
Wong, Chi Chun [2 ]
Yu, Jun [2 ]
机构：
[1] Shenzhen Univ, Dept Gastroenterol, Gen Hosp, Clin Med Acad, Shenzhen, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
来源：
GUT | 2019年 / 68卷
关键词：
D O I：
10.1136/gutjnl-2019-IDDFabstracts.38
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2019-A
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [1] AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway
    Yang, Haifeng
    Wan, Zhenzhou
    Huang, Cheng
    Yin, Huabin
    Song, Dianwen
    LASERS IN MEDICAL SCIENCE, 2019, 34 (03) : 473 - 478
  • [2] AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway
    Haifeng Yang
    Zhenzhou Wan
    Cheng Huang
    Huabin Yin
    Dianwen Song
    Lasers in Medical Science, 2019, 34 : 473 - 478
  • [3] The Ras-Raf-MEK-ERK pathway in the treatment of cancer
    Hilger, RA
    Scheulen, ME
    Strumberg, D
    ONKOLOGIE, 2002, 25 (06): : 511 - 518
  • [4] Prohibitins Role in Cellular Survival Through Ras-Raf-MEK-Erk Pathway
    Chowdhury, Indrajit
    Thompson, Winston E.
    Thomas, Kelwyn
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (08) : 998 - 1004
  • [5] RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway
    Xie, Guojin
    Wu, Haiyan
    Cai, Weiluo
    Chen, Mo
    Huang, Wending
    Yan, Wangjun
    Chang, Yong
    FEBS OPEN BIO, 2019, 9 (03): : 490 - 497
  • [6] Tax1 Enhances Cancer Cell Proliferation via Ras-Raf-MEK-ERK Signaling Pathway
    Song, Chunjiao
    Wang, Weimin
    Li, Meng
    Liu, Yanxin
    Zheng, Dexian
    IUBMB LIFE, 2009, 61 (06) : 685 - 692
  • [7] Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials
    Song, Yanlin
    Bi, Zhenfei
    Liu, Yu
    Qin, Furong
    Wei, Yuquan
    Wei, Xiawei
    GENES & DISEASES, 2023, 10 (01) : 76 - 88
  • [8] Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway
    Nicola, Pantelis A.
    Burghel, George
    Wallace, Andrew
    Schlecht, Helene
    Baker, Eleanor
    Baker, Katie
    Priest, Lynsey
    Carter, Mathew
    Moghadam, Sharzad
    Rogan, Jane
    Bristow, Robert G.
    Newman, William
    Blackhall, Fiona
    Lindsay, Colin R.
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
    Avery, Thomas Yul
    Koehler, Natalie
    Zeiser, Robert
    Brummer, Tilman
    Ruess, Dietrich Alexander
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] KSR1 as a therapeutic target for hepatocellular carcinoma with activated RAS-RAF-MEK-ERK signaling pathway
    Moon, H.
    Park, H.
    Jun, M.
    Lee, S.
    Lee, S.
    Lee, J.
    Ro, S. W.
    ANNALS OF ONCOLOGY, 2024, 35 : S220 - S221
12345